Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy

被引:87
作者
Agarwal, Anika [1 ,2 ]
Tressel, Sarah L. [1 ]
Kaimal, Rajani [1 ]
Balla, Marianthi [1 ]
Lam, Francis H. [1 ]
Covic, Lidija [1 ,2 ,3 ,4 ]
Kuliopulos, Athan [1 ,2 ,3 ,4 ]
机构
[1] Tufts Univ, Sch Med, Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Tufts Med Ctr, Dept Med, Boston, MA 02111 USA
[3] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA
[4] Tufts Univ, Sch Med, Dept Genet, Boston, MA 02111 USA
关键词
GROWTH-REGULATED ONCOGENE; BREAST-CANCER; THROMBIN-RECEPTOR; STROMAL FIBROBLASTS; PANCREATIC-CANCER; GENE-EXPRESSION; CELLS; ANGIOGENESIS; INVASION; PAR1;
D O I
10.1158/0008-5472.CAN-09-4341
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian cancer is a lethal gynecologic malignancy that may benefit from new therapies that block key paracrine pathways involved in tumor-stromal interactions and tumor vascularity. It was recently shown that matrix metalloprotease-1 (MMP1) activation of the G protein-coupled receptor protease-activated receptor-1 (PAR1) is an important stimulator of angiogenesis and metastasis in peritoneal mouse models of ovarian cancer. In the present study, we tested the hypothesis that MMP1-PAR1 promotes angiogenesis through its paracrine control of angiogenic chemokine receptors. We found that MMP1-PAR1 activation induces the secretion of several angiogenic factors from ovarian carcinoma cells, most prominently interleukin (IL)-8, growth-regulated oncogene-alpha (GRO-alpha), and monocyte chemoattractant protein-1. The secreted IL-8 and GRO-alpha acts on endothelial CXCR1/2 receptors in a paracrine manner to cause robust endothelial cell proliferation, tube formation, and migration. A cell-penetrating pepducin, X1/2pal-i3, which targets the conserved third intracellular loop of both CXCR1 and CXCR2 receptors, significantly inhibited endothelial cell proliferation, tube formation, angiogenesis, and ovarian tumor growth in mice. Matrigel plugs mixed with MMP1-stimulated, OVCAR-4-conditioned media showed a dramatic 33-fold increase in blood vessel formation in mice. The X1/2pal-i3 pepducin completely inhibited MMP1-dependent angiogenesis compared with a negative control pepducin or vehicle. Conversely, a vascular endothelial growth factor-directed antibody, Avastin, suppressed angiogenesis in mice but, as expected, was unable to inhibit IL-8 and GRO-alpha-dependent endothelial tube formation in vitro. These studies identify a critical MMP1-PAR1-CXCR1/2 paracrine pathway that might be therapeutically targeted for ovarian cancer treatment. Cancer Res; 70(14); 5880-90. (C)2010 AACR.
引用
收藏
页码:5880 / 5890
页数:11
相关论文
共 50 条
  • [1] Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
    Agarwal, Anika
    Covic, Lidija
    Sevigny, Leila M.
    Kaneider, Nicole C.
    Lazarides, Katherine
    Azabdaftari, Gissou
    Sharifi, Sheida
    Kuliopulos, Athan
    [J]. MOLECULAR CANCER THERAPEUTICS, 2008, 7 (09) : 2746 - 2757
  • [2] Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor
    Andrade-Gordon, P
    Mayanoff, BE
    Derian, CK
    Zhang, HC
    Addo, MF
    Darrow, AL
    Eckardt, AJ
    Hoekstra, WJ
    McComsey, DF
    Oksenberg, D
    Reynolds, EE
    Santulli, RJ
    Scarborough, RM
    Smith, CE
    White, KB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) : 12257 - 12262
  • [3] The agonist of the protease-activated receptor-1 (PAR1) but not PAR3 mimics thrombin-induced vascular endothelial growth factor release in human vascular smooth muscle cells
    Arisato, T
    Sarker, KP
    Kawahara, K
    Nakata, M
    Hashiguchi, T
    Osame, M
    Kitajima, I
    Maruyama, I
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (08) : 1716 - 1724
  • [4] Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion
    Arora, P.
    Cuevas, B. D.
    Russo, A.
    Johnson, G. L.
    Trejo, J.
    [J]. ONCOGENE, 2008, 27 (32) : 4434 - 4445
  • [5] Cancer and the chemokine network
    Balkwill, F
    [J]. NATURE REVIEWS CANCER, 2004, 4 (07) : 540 - 550
  • [6] The biology of ovarian cancer: new opportunities for translation
    Bast, Robert C., Jr.
    Hennessy, Bryan
    Mills, Gordon B.
    [J]. NATURE REVIEWS CANCER, 2009, 9 (06) : 415 - 428
  • [7] A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis
    Blackburn, J. S.
    Liu, I.
    Coon, C. I.
    Brinckerhoff, C. E.
    [J]. ONCOGENE, 2009, 28 (48) : 4237 - 4248
  • [8] PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells
    Boire, A
    Covic, L
    Agarwal, A
    Jacques, S
    Sherifl, S
    Kuliopulos, A
    [J]. CELL, 2005, 120 (03) : 303 - 313
  • [9] Experience with bevacizumab in the management of epithelial ovarian cancer
    Burger, Robert A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (20) : 2902 - 2908
  • [10] Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis
    Caunt, M
    Hu, L
    Tang, T
    Brooks, PC
    Ibrahim, S
    Karpatkin, S
    [J]. CANCER RESEARCH, 2006, 66 (08) : 4125 - 4132